NRD
CDNA icon

Nebula Research & Development’s CareDx CDNA Stock Holding History

Nebula Research & Development’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,374
Closed -$281K – 157
2025
Q2 		$281K Buy
+14,374
New +$255K 0.02% 804
2025
Q1 		– Sell
-33,180
Closed -$710K – 972
2024
Q4 		$710K Sell
33,180
-3,165
-9% -$77K 0.08% 419
2024
Q3 		$1.13M Buy
36,345
+6,471
+22% +$161K 0.14% 252
2024
Q2 		$464K Sell
29,874
-3,949
-12% -$47.7K 0.08% 457
2024
Q1 		$358K Sell
33,823
-11,344
-25% -$113K 0.08% 469
2023
Q4 		$542K Buy
+45,167
New +$370K 0.16% 227
2023
Q3 		– Sell
-42,888
Closed -$365K – 506
2023
Q2 		$365K Buy
42,888
+19,022
+80% +$159K 0.28% 182
2023
Q1 		$218K Buy
+23,866
New +$305K 0.39% 163

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Nebula Research & Development's CDNA Position: Q3 2025 in Review

Nebula Research & Development sold out of CareDx (CDNA) in Q3 2025, closing a stake of 14,374 shares — an estimated $281K sold.

Nebula Research & Development first reported a position in CDNA in Q1 2023 and held it in 8 quarters. The position peaked at $1.13M in Q3 2024. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

  • Nebula Research & Development reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 14,374 CareDx shares in Q3 2025, an estimated $281K.
  • Nebula Research & Development first reported a position in CareDx in Q1 2023 and held it in 8 quarters.
  • Nebula Research & Development's CareDx position peaked at $1.13M in Q3 2024.
  • 187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.